Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 7/2004

01-07-2004 | Short Communication

99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules

Authors: Anna Płachcińska, Renata Mikołajczak, Helmut R. Maecke, Andrzej Michalski, Katarzyna Rzeszutek, Józef Kozak, Jacek Kuśmierek

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 7/2004

Login to get access

Abstract

Forty-three consecutive patients with solitary pulmonary nodules (SPNs) on chest radiographs were studied scintigraphically after administration of the somatostatin analogue 99mTc-EDDA/HYNIC-TOC. The objective of the study was to assess the usefulness of the procedure for differentiation of SPNs as malignant or benign. The administered activity was 740–925 MBq, and a single-photon emission computed tomography imaging technique was employed. Verification of the nodule aetiology was based on histology or cytology and bacteriology. A stable tumour size on chest radiography for at least 3 years was accepted as an additional criterion of benignity. In 29 patients, nodules were found to be malignant. The diagnoses included ten adenocarcinomas, five squamous cell carcinomas, two large cell carcinomas, six non-small cell lung cancers without specification of the more detailed morphology, two small cell lung cancers, two typical carcinoids and two metastatic tumours (leiomyosarcoma and malignant melanoma). In 14 patients the following benign tumours were diagnosed: four tuberculomas, one other granuloma, three hamartomas, one non-specific inflammatory infiltrate, one abscess, one peripheral carcinoid with the morphological characteristics of a benign tumour, one ectopic lesion of thyroid tissue and two benign tumours of unspecified aetiology with a stable size over 3 and 5 years respectively. Positive scintigraphic results were obtained in 26 of the 29 patients (90%) with malignant SPNs; among these, 24 of the 25 (96%) cases of primary pulmonary carcinoma yielded positive results. The remaining two false negative cases were the metastatic tumours, liposarcoma and melanoma. Of the 14 benign lesions, ten (71%) did not accumulate the radiopharmaceutical. The remaining four benign tumours that were visible on scintigrams comprised one tuberculoma, one hamartoma, one abscess and one case in which the diagnosis could not be established (the tumour had a stable size over 3 years). In conclusion, scintigraphy with 99mTc-EDDA/HYNIC-TOC appears to be an effective procedure for differentiation between malignant and benign SPNs. A fully credible assessment of the clinical efficacy of this procedure requires further study in a larger number of patients.
Literature
1.
go back to reference Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in solitary pulmonary nodule. Comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997; 112:416–422.PubMed Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in solitary pulmonary nodule. Comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997; 112:416–422.PubMed
2.
go back to reference Gambhir SS, Shepherd JE, Shah BD, Hart E, Hah CK, Valk PE, Emi T, Phelps ME. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 1998; 16:2113–2125.PubMed Gambhir SS, Shepherd JE, Shah BD, Hart E, Hah CK, Valk PE, Emi T, Phelps ME. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 1998; 16:2113–2125.PubMed
3.
go back to reference Lowe VJ, Hoffman JMM, De Jong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771–1776.PubMed Lowe VJ, Hoffman JMM, De Jong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771–1776.PubMed
4.
go back to reference Blum J, Handmaker H, Lister-James J. A multicenter trial with a somatostatin analogue99mTc-depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117:1232–1238.PubMed Blum J, Handmaker H, Lister-James J. A multicenter trial with a somatostatin analogue99mTc-depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117:1232–1238.PubMed
5.
go back to reference Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooji PPM, Oei HY, van Hagen M, Postema PTE, De Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ Koper JW., Lamberts SWJ. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20:716–731.PubMed Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooji PPM, Oei HY, van Hagen M, Postema PTE, De Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ Koper JW., Lamberts SWJ. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20:716–731.PubMed
6.
go back to reference Płachcińska A, Mikołajczak R, Maecke HR, Młodkowska E, Kunert-Radek J, Michalski A, Rzeszutek K, Kozak J, Kuśmierek J. Clinical usefulness of99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics—a preliminary communication. Eur J Nucl Med. Mol Imaging 2003; 30:1402–1406.CrossRefPubMed Płachcińska A, Mikołajczak R, Maecke HR, Młodkowska E, Kunert-Radek J, Michalski A, Rzeszutek K, Kozak J, Kuśmierek J. Clinical usefulness of99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics—a preliminary communication. Eur J Nucl Med. Mol Imaging 2003; 30:1402–1406.CrossRefPubMed
7.
go back to reference Płachcińska A, Mikołajczak R, Maecke HR, Młodkowska E, Kunert-Radek J, Michalski A, Rzeszutek K, Kozak J, Kuśmierek J. Clinical usefulness of99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics—a pilot study. Cancer Biother Radiopharm 2004; to be published. Płachcińska A, Mikołajczak R, Maecke HR, Młodkowska E, Kunert-Radek J, Michalski A, Rzeszutek K, Kozak J, Kuśmierek J. Clinical usefulness of99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics—a pilot study. Cancer Biother Radiopharm 2004; to be published.
8.
go back to reference Decristoforo C, Mather SJ. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence. Eur J Nucl Med 1999; 26:869–976.CrossRefPubMed Decristoforo C, Mather SJ. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence. Eur J Nucl Med 1999; 26:869–976.CrossRefPubMed
9.
go back to reference Decristoforo C, Mendelez-Alafort L, Sosabowski JK, Mather SJ.99mTc-HYNIC-[Tyr3]-octreotide for imaging of somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. J Nucl Med 2000; 41:1114–1119.PubMed Decristoforo C, Mendelez-Alafort L, Sosabowski JK, Mather SJ.99mTc-HYNIC-[Tyr3]-octreotide for imaging of somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. J Nucl Med 2000; 41:1114–1119.PubMed
10.
go back to reference Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology 1993; 186:405–413.PubMed Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology 1993; 186:405–413.PubMed
11.
go back to reference Bedford M, Maisey MN. Requirements for clinical PET: comparison within Europe. Eur J Nucl Med Mol Imaging 2004; 31:208–221.CrossRef Bedford M, Maisey MN. Requirements for clinical PET: comparison within Europe. Eur J Nucl Med Mol Imaging 2004; 31:208–221.CrossRef
12.
13.
go back to reference Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914–924.PubMed Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914–924.PubMed
14.
go back to reference Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997; 205:471–478.PubMed Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997; 205:471–478.PubMed
15.
go back to reference Swensen S, Brown LR, Colby TV. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995; 194:393–398.PubMed Swensen S, Brown LR, Colby TV. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995; 194:393–398.PubMed
16.
go back to reference Sortini A, Carcoforo P, Simona A, Sortini D, Pozza E. Significance of a single pulmonary nodule in patients with previous history of malignancy. Eur J Cardiothorac Surg 2001; 20:1101–1005.PubMed Sortini A, Carcoforo P, Simona A, Sortini D, Pozza E. Significance of a single pulmonary nodule in patients with previous history of malignancy. Eur J Cardiothorac Surg 2001; 20:1101–1005.PubMed
Metadata
Title
99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules
Authors
Anna Płachcińska
Renata Mikołajczak
Helmut R. Maecke
Andrzej Michalski
Katarzyna Rzeszutek
Józef Kozak
Jacek Kuśmierek
Publication date
01-07-2004
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2004
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1511-3

Other articles of this Issue 7/2004

European Journal of Nuclear Medicine and Molecular Imaging 7/2004 Go to the issue

Announcements

July 2004